A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

NCT06190886 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Solid Tumor
Metastatic Cancer

Interventions

DRUG: PTX-912

Sponsor

Proviva Therapeutics, Inc.